Aerospace & Defensegoverned model lifecycle managementproposed regulatory workflow described in fda draft guidance; not final policy in the source.

Predetermined Change Control Plan for AI/ML-enabled medical device software

A manufacturer tells regulators in advance what AI software updates it expects to make, how it will test them, and how it will keep the device safe after release.

10.0

Quality
Score

Executive Brief

Business Problem Solved

Premium content - unlock to see the business problem analysis...

Value Drivers

Value Driver 1Value Driver 2

Strategic Moat

Premium content - unlock to see strategic analysis...

Premium Access

Full Analysis Available

Executive brief, technical architecture, and market positioning for this use case.

Aerospace Defense — $499/yr Atlas Pro — $1,499/yr

Executive Brief•Technical•Market Signal

Technical Analysis

Model Strategy

Premium content...

Data Strategy

Premium content...

Implementation Complexity

Premium content...

Scalability Bottleneck

Premium content...

Premium Access

Full Analysis Available

Executive brief, technical architecture, and market positioning for this use case.

Aerospace Defense — $499/yr Atlas Pro — $1,499/yr

Executive Brief•Technical•Market Signal

Market Signal

Adoption Stage

Premium content...

Differentiation Factor

Premium content...

Key Competitors

Company ACompany B

Premium Access

Full Analysis Available

Executive brief, technical architecture, and market positioning for this use case.

Aerospace Defense — $499/yr Atlas Pro — $1,499/yr

Executive Brief•Technical•Market Signal

Part of Application

Computational Drug Discovery

21 use cases in this application

Explore More

More in Aerospace & Defense→More governed model lifecycle management→

Source

https://fda.gov/media/167353/download